CMS Officials Stress Coverage Decision Timeline At ACLA Panel

Device developers who want to ensure the best possible reimbursement for their products should be thoughtful in how they approach the US Centers for Medicare and Medicaid Services, agency officials said during a recent meeting.

Green road sign reading "Medicare Just Ahead"
• Source: Shutterstock

If you want the Centers for Medicare and Medicaid Services to help obtain the most appropriate reimbursement for your product, understanding where you are in the process is crucial.

That was the main takeaway from a CMS panel at the recent American Clinical Laboratory Association (ACLA) annual meeting in...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from United States

More from North America